Extended indication for Relistor
Relistor (methylnaltrexone bromide; TMC Pharma Services) is now indicated for opioid-induced constipation when response to laxative therapy has not been sufficient in adults aged 18 years and older. Further changes to the summary of product characteristics reflect this license extension.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069052
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com